34 GHP Healthcare & Pharma Awards 2022 Being one of the most efficient, reliable, and reimbursable integrated mobile health platforms, MiCare Path has propelled itself into the spotlight of its industry capturing the Healthcare Start-Up of the Year 2022 Award from GHP Healthcare & Pharma. Above all else, MiCare Path’s goal is to usher in the future of healthcare, today, by partnering with providers to build a closer connection to an ever-growing specialty care patient population, delivering improved outcomes with data-driven decisions, personalizing both patient education and care paths to promote clinical efficiencies for a better overall patient experience. Healthcare Start-Up of the Year 2022 - USA n an industry that has seen an increase in demand since the beginning of the pandemic with no signs of slowing down, MiCare Path believes quality healthcare and patientphysician touchpoints should not be limited to in-office availability or a patient’s zip code. MiCare Path is on a mission to deliver the efficient healthcare of the future, today. They do this through behavioral change-driven clinical pathways, actionable data, and insights, and ultimately improved healthcare outcomes through real-time connectivity between physicians and patients, beyond the office visit. MiCare Path is redefining technology’s place within the specialty care market through its user-friendly remote patient monitoring (RPM) and remote therapeutic monitoring (RTM) solutions. In collaboration with more than 75 global healthcare thought leading providers, MiCare Path is delivering a unique approach to digital innovation rooted in the science of behavioral change to increase patient compliance and engagement while delivering more comprehensive specialty care. Over time, MiCare Path anticipates that this will foster the creation of further innovative and scalable solutions. Its platform is already one of the market leaders for RPM and cRTM by providing comprehensive programs for specialty healthcare management. MiCare Path’s current trajectory towards greater success has, after all, been made possible by the patients, the providers and health systems, and their success stories. These stories range from successful blood pressure and glucose reduction to discovering previously undetected heart conditions and bone microfractures. Remote management in these cases contributed to life-saving interventions, emergency room visit reductions, and elevating reach through highly personalized care for patients. Recently, MiCare Path has partnered with several large independent physician groups and institutions covering the musculoskeletal and cardiology spaces and now enjoys exclusive access to approximately 1% of both markets in the US, which totals nearly 2.5 million people. Thus, going forward, MiCare Path will continue to push toward helping more people, by providing the best remote healthcare solutions to help prevent serious medical events, increase clinical efficiency and visibility, and establish a more open line of communication between patient and provider. Focusing on the core of specialty care, the MiCare Path platform is providing peace of mind to providers and patients beyond the office visit. I Jul22287 MiCare Path is on a mission to deliver the efficient healthcare of the future, today. They do this through behavioral changedriven clinical pathways, actionable data and insights, and ultimately improved healthcare outcomes through real-time connectivity between physicians and patients, beyond the office visit.